Carregant...
Transcriptional inhibitors identified in a 160,000-compound small molecule DUX4-viability screen
FSHD is a genetically dominant currently untreatable muscular dystrophy. It is caused by mutations that enable expression of the normally silent DUX4 gene, which encodes a pathogenic transcription factor. A screen based on Tet-on DUX4-induced mouse myoblast death previously uncovered compounds from...
Guardat en:
| Publicat a: | J Biomol Screen |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5501317/ https://ncbi.nlm.nih.gov/pubmed/27245141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1087057116651868 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|